Subdural empyema in immunocompetent pediatric patients with recent SARS-CoV-2 positivity: case report

Uğur Yazar1, Zeynep Gökçe Gayretli Aydın2, Ahmet Kağan Özkaya3

  • 1Department of Neurosurgery, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey. uguryazar@yahoo.com.

Insights

Pediatric subdural empyema, a rare complication of COVID-19, occurred in two children. Prompt diagnosis and surgical intervention led to full neurological recovery, highlighting the need for vigilance.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Pediatrics

Background:

  • Subdural empyema is a serious infection typically caused by bacterial meningitis or other infections.
  • Coronaviruses (CoV), including SARS-CoV-2, are increasingly recognized for their neurotropic potential and association with neurological complications in adults.
  • While CoV-related neurological issues are documented in adults, their occurrence in pediatric subdural empyema remains less understood.

Observation:

  • Two pediatric patients, aged 15 and 12, developed subdural empyema following SARS-CoV-2 infection.
  • Clinical presentation included ophthalmoplegia, aphasia, drowsiness, fever, and vomiting, with positive COVID-19 tests.
  • Magnetic Resonance Imaging (MRI) confirmed subdural empyema, necessitating surgical intervention for intracranial pressure management and pus drainage.

Findings:

  • Microbiological analysis of the empyema revealed Streptococcus constellatus, an uncommon pathogen in immunocompetent children.
  • Patients received broad-spectrum antibiotics followed by targeted intravenous antibiotic therapy.
  • Both patients achieved complete neurological recovery after treatment.

Implications:

  • This case series underscores the potential for SARS-CoV-2 to trigger severe neurological complications like subdural empyema in pediatric patients.
  • It emphasizes the importance of close neurological monitoring in children with CoV infections.
  • Further research is crucial to elucidate the correlation between CoV infections and pediatric neurological diseases for improved recognition and treatment strategies.